Cencora, Inc. (LON:0HF3)
London · Delayed Price · Currency is GBP · Price in USD 335.89
-7.04 (-2.05%)
Jan 9, 2026, 5:04 PM GMT
Cencora Market Cap
Cencora has a market cap or net worth of 48.49 billion as of January 9, 2026. Its market cap has increased by 38.53% in one year.
Market Cap
48.49B
Enterprise Value
52.37B
Revenue
239.05B
Ranking
n/a
PE Ratio
41.94
Stock Price
335.89
Market Cap Chart
Since April 4, 1995, Cencora's market cap has increased from 199.85M to 48.49B, an increase of 24,163.08%. That is a compound annual growth rate of 19.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 48.49B | -0.39% |
| Dec 31, 2025 | 48.68B | 40.35% |
| Dec 31, 2024 | 34.69B | 8.10% |
| Dec 29, 2023 | 32.09B | 15.46% |
| Dec 30, 2022 | 27.79B | 36.06% |
| Dec 31, 2021 | 20.43B | 39.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 220.60B |
| GSK plc | 76.29B |
| Haleon | 33.53B |
| Smith & Nephew | 10.66B |
| Convatec Group | 4.75B |
| Hikma Pharmaceuticals | 3.51B |
| HUTCHMED (China) | 1.81B |
| Genus | 1.72B |